Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Hong Kong ETF (EWH) vs 10X Genomics Inc (TXG) Price & Performance

iShares MSCI Hong Kong ETFTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Hong Kong ETF vs 10X Genomics Inc — how do they compare? iShares MSCI Hong Kong ETF trades at $22.45, while 10X Genomics Inc trades at $57.69 (market cap $7.61B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, iShares MSCI Hong Kong ETF nearer its low. Which is the better fit depends on your goals.

EWHTXG
Sector
Broad Market / FactorHealth
52-Week High
$24.55$58.57
52-Week Low
$20.66$11.34
Market Cap
$7.61B
Enterprise Value
$7.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Hong Kong ETF

EWH, a US-listed stock tracking Hong Kong equities, trades at $22.465, down 1.47% over 24 hours. Technical indicators signal a bearish trend with moving averages in sell territory, though oscillators are neutral. The stock faces resistance at $23 and support at $22. Recent news highlights the Hang Seng Index's rebound, driven by technology sector gains, with EWH positioned to benefit from this momentum.

The outlook for EWH hinges on Hong Kong market performance, with potential upside from continued tech recovery and Asian market stability. Risks include regional volatility and macroeconomic pressures. Analysts show mixed sentiment, balancing technical bearishness with fundamental opportunities in the rebounding index.

10X Genomics Inc

TXG trades at $58.57, up 12.57% in 24 hours, reflecting strong momentum. The stock is technically bullish with moving averages supporting the uptrend, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and revenue growth, yet remains unprofitable with a negative net income margin. Recent news highlights collaborations and acquisitions expanding its genomic capabilities.

Outlook is mixed; analyst consensus is neutral with a $46 price target below current levels, indicating caution despite recent beats. Key risks include sustained losses and competitive pressures, but operational cash flow growth and strategic expansions offer potential upside for patient investors focused on long-term biotech innovation.

Returns comparison

Trailing returns across standard periods

About iShares MSCI Hong Kong ETF

EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.

Read more on EWH

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG